Upcoming Presentations

Vernalis will be speaking at the following meetings:


  • 13-16 March 2016,  ACS San Diego
  • 19-22 April 2016, CHI Drug Discovery Chemistry, San Diego
  • 12-13 May 2016, GTCBio Drug Discovery, Berlin
  • 7-10 June 2016, 3rd NovAliX Biophysics Conference, Strasbourg
  • 12-13 June 2016, GTC Bio: 2nd Kinase Inhibitors Design & Screening, Berlin
  • 15-16 June 2016, Global Structural Drug Design Summit, Lisbon
  • 12-15 July FBDD Down-Under, Melbourne, Australia
  • 9-10 October 2016, FBLD2016, Cambridge, MA


  • 6-7 March 2017, Drug Discovery, Selectbio, Cambridge, UK

Latest News

Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration

Servier and Vernalis plc are pleased to announce the achievement of two research milestones and one clinical milestone in their oncology drug discovery collaboration, triggering a total payment of €2 million to Vernalis.

Read more ...

Product Pipeline

For more information on our pipeline, click below to visit Vernalis plc

Commercial Pipeline

Comm-thumbnailExplore the pipeline ...


NCE Pipeline

NCE-thumbnailExplore the pipeline ...


Contact Vernalis Research

T: (0)1223 895555
F: (0)1223 895556

Contact information
Maps and directions
Contact form

Fact Sheet

For more information on Vernalis, click on the below image to download a copy of our fact sheet

Vernalis Factsheet May 2015 Page 1